TANG CAPITAL MANAGEMENT LLC Diversified Active

Location: San Diego, CA

CIK: 0001232621 · Show all filings

Period: Q1 2014 (← Previous) (Next →)

Filing Date: May 15, 2014

Total Value: $206M (71.3% shares, 28.7% debt)

Holdings (13)

HRTX HERON THERAPEUTICS INC 29.7%
Value $61.33M Shares 4,408,987 Share Price $13.91 * Est. Cost/Share $12.60 Unrealized @ Report Date 0.0%
— PDL BIOPHARMA INC 19.5%
Value $40.2M Shares 25,974,000 Share Price $1.55 Est. Cost/Share $1.41 Unrealized @ Report Date —
— SALIX PHARMACEUTICALS INC 15.1%
Value $31.08M Shares 300,000 Share Price $103.61 Est. Cost/Share $66.15 Unrealized @ Report Date —
— OPKO HEALTH INC 9.2%
Value $19.04M Shares 14,000,000 Share Price $1.36 Est. Cost/Share $1.04 Unrealized @ Report Date —
— HORIZON PHARMA INC 7.3%
Value $15.12M Shares 1,000,000 Share Price $15.12 Est. Cost/Share $15.12 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 6.0%
Value $12.44M Shares 182,300 Share Price $68.21 * Est. Cost/Share $62.32 Unrealized @ Report Date +18.3%
— ENDOCYTE INC 5.4%
Value $11.09M Shares 465,763 Share Price $23.81 Est. Cost/Share $13.13 Unrealized @ Report Date —
— MIRATI THERAPEUTICS INC 4.0%
Value $8.312M Shares 435,843 Share Price $19.07 Est. Cost/Share $15.15 Unrealized @ Report Date —
— MANNKIND CORP 3.5%
Value $7.236M Shares 1,800,000 Share Price $4.02 Est. Cost/Share $4.72 Unrealized @ Report Date —
— DENDREON CORP 0.1%
Value $166K Shares 55,548 Share Price $2.99 Est. Cost/Share $4.12 Unrealized @ Report Date —
— LA JOLLA PHARMACEUTICAL CO 0.1%
Value $121K Shares 11,219 Share Price $10.79 Est. Cost/Share $10.79 Unrealized @ Report Date —
— RXI PHARMACEUTICALS CORP 0.0%
Value $78,000 Shares 18,245 Share Price $4.28 Est. Cost/Share $4.28 Unrealized @ Report Date —
— AMBIT BIOSCIENCES CORP 0.0%
Value $0 Shares 46 Share Price $0.00 Est. Cost/Share — Unrealized @ Report Date —